Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation in patients with or without diabetes: a patient-level meta-analysis of randomised trials
Clinical outcomes in patients with diabetes mellitus receiving dual antiplatelet therapy more than 12 months after second-generation drug eluting stent implantation